With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

In the race to build increasingly autonomous AI agents, the community has focused heavily on improving agents’ capabilities ...

Wang Zhi, dean of the School of Fine Arts, explained, "Through this theme, we aim to anchor intellectual weight in an era of ...

In this essay by Edgar Calabia Samar, he shows how Eka Kurniawan’s 'Beauty Is a Wound' teaches us to dream at multiple scales ...

Previously, we watched Tim Berners-Lee knit the world together with the Web, giving us pages to browse and links to click. But a web of information is ...

Morgan Stanley recently projected a US power shortfall through 2028, totaling 45 gigawatts (20% of total data center demand), ...

Thank you for signing up! Did you know with a Digital subscription to Yorkshire Post, you can get access to all of our premium content, as well as benefiting from fewer ads, loyalty rewards and much ...

We got to check out Jonathan Blow's Order Of The Sinking Star ahead if The Game Awards premiere and event asked him a few questions.

Google has released its Deep Research agent to developers via the Interactions API, undercutting OpenAI with low pricing and ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...